12 /100
LOW RISK
Score updated May 29, 2026

RIGL — Rigel Pharmaceuticals, Inc. Dilution Risk Tracker

Track RIGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RIGL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RIGL.
🔔 Track RIGL — Get forecast alerts →

💹 Market Data

Market Cap$555.99M
Shares Outstanding18.50M
Float15.95M
Cash$146.68M
Debt$45.72M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 66.0% shares (2025Q4 vs prior)
15 institutional holders · 156.8K shares
#1 Quinn Opportunity Partners LLC 41.4K shares
#2 Concorde Asset Management, LLC 27.2K shares
#3 VANGUARD GROUP INC 24.7K shares
+ 12 more holders Sign up free to view →

📉 Short Interest

Short Interest3.94M
Days to Cover12.1
% of Float24.7%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2011
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track RIGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RIGL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for RIGL
📊 RIGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RIGL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.